Destiny Pharma – Result of General Meeting and Total Voting Rights

Link to Full Article Destiny Pharma plc  (“Destiny” or the “Company”) Result of General Meeting  and Total Voting Rights  Brighton, United Kingdom ‐ 26 November 2020: Destiny Pharma plc (AIM:DEST) a clinical stage biotechnology company focused on the development of novel products to prevent life threatening infections, announces that, at the General Meeting held earlier […]

Destiny Pharma announces total gross proceeds raised via Open Offer

Link to Full Article Destiny Pharma plc (“Destiny” or the “Company”) Result of Open Offer Brighton, United Kingdom ‐ 25 November 2020: Destiny Pharma plc (AIM:DEST) a clinical stage biotechnology company focused on the development of novel products to prevent life threatening infections, announces that it has conditionally raised total gross proceeds of approximately £0.87m […]

Adherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory company

Link to Full Article Melbourne, Australia – 24 November 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie® platform and technology into specialist respiratory centres in […]

Minister for Industry, Science and Technology $41.7 million boost to commercialise lifesaving medical discoveries

Link to Full Article Joint media release with Minister for Industry, Science and Technology, Karen Andrews, announcing $500 million to take an innovative nasal treatment to fight COVID-19, common colds and flu to the next stage of testing. An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next […]

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Link to Full Article New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom – 9 November 2020 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion of […]